ESCRS - Measuring tear film thickness ;
ESCRS - Measuring tear film thickness ;

Measuring tear film thickness

A customised broad spectrum OCT device can reliably measure tear film thickness without touching the ocular surface

Measuring tear film thickness
A customised broad spectrum OCT device can reliably measure tear film thickness without touching the ocular surface, according to  Gerhard Garhöfer MD, of the Medical University of Vienna, Austria. He expects commercial versions will be available soon that will give clinicians a user-independent measure of tear film break up time that will be helpful for diagnosing and monitoring dry eye disease. Dr Garhöfer conducted a study using ultra-high resolution OCT for assessing tear film thickness in 60 dry eye patients before and after administration of three commercial gel lubricants: hyaluronic acid 0.15% plus 3.0% trehalose (Thealoz Duo Gel); hyaluronic acid 0.2% (Hylo Gel); polyethylene glycol 0.4% plus propylene glycol 0.3% (Systane Gel). While 10 minutes after administration a pronounced increase in tear film thickness was observed in all three groups, hyaluronic acid with trehalose significantly maintained the increase in tear film for up to two hours, Dr Garhöfer reported. Beyond these immediate findings on dry eye gels, the study demonstrates that high resolution OCT can measure tear film without contacting the ocular surface, and provides operator-independent results. Drawbacks of the custom device include limitation to a 3.0mm segment of the ocular surface, and the high cost of light sources that can deliver approximately 1.0 micron resolution required for tear surface evaluation, Dr Garhöfer said. “We are working to make it larger so we can cover the whole surface so we can see exactly where the break up happens,” Dr Garhöfer said. He expects OCT machines with this capability will be commercially available soon. Gerhard Garhöfer: gerhard.garhoefer@meduniwien.ac.at
Latest Articles
From Lab to Life: Corneal Repair Goes Cellular

Long-awaited cellular therapies for corneal endothelial disease enter the clinic.

Read more...

Balancing Innovation and Safety

Ensuring access to advanced cell therapies amid regulatory overhaul.

Read more...

With Eyes on Its Future, ESCRS Celebrates Its Past

Winter Meeting offers opportunities to experiment with new concepts and formats.

Read more...

Best of ESCRS Winter Meeting 2024

Read more...

Following the New Generation

EDOF IOLs an option for eyes with mild comorbidities, showing potential in mini-monovision strategies.

Read more...

Refocus on Multifocals

Trifocal IOLs continue to improve as consensus grows regarding indications and contraindications.

Read more...

Common Myths in Presbyopia Correction

Patient education key to satisfaction with refractive IOLs.

Read more...

Reversible Multifocality

Two-lens combination offers low-risk spectacle independence for cataract patients and presbyopes.

Read more...

Managing a Cataract Surgery Refractive Miss

Weighing the pros and cons of options for intraocular intervention.

Read more...

Unleashing OCT’s Full Potential

Performance of newest tool for corneal evaluation meets or beats older standard technologies.

Read more...

;